Tomonobu Nahoko, Kinoshita Rie, Sakaguchi Masakiyo
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama-shi, Okayama 700-8558, Japan.
Transl Oncol. 2020 Apr;13(4):100753. doi: 10.1016/j.tranon.2020.100753. Epub 2020 Mar 17.
The molecular mechanisms underlying the 'seed and soil' theory are unknown. S100A8/A9 (a heterodimer complex of S100A8 and S100A9 proteins that exhibits a 'soil signal') is a ligand for Toll-like receptor 4, causing distant melanoma cells to approach the lung as a 'seeding' site. Unknown soil sensors for S100A8/A9 may exist, e.g., extracellular matrix metalloproteinase inducer, neuroplastin, activated leukocyte cell adhesion molecule, and melanoma cell adhesion molecule. We call these receptor proteins 'novel S100 soil sensor receptors (novel SSSRs).' Here we review and summarize a crucial role of the S100A8/A9-novel SSSRs' axis in cancer metastasis. The binding of S100A8/A9 to individual SSSRs is important in cancer metastasis via upregulations of the epithelial-mesenchymal transition, cellular motility, and cancer cell invasiveness, plus the formation of an inflammatory immune suppressive environment in metastatic organ(s). These metastatic cellular events are caused by the SSSR-featured signal transductions we identified that provide cancer cells a driving force for metastasis. To deprive cancer cells of these metastatic forces, we developed novel biologics that prevent the interaction of S100A8/A9 with SSSRs, followed by the efficient suppression of S100A8/A9-mediated lung-tropic metastasis in vivo.
“种子与土壤”理论背后的分子机制尚不清楚。S100A8/A9(一种表现出“土壤信号”的S100A8和S100A9蛋白的异二聚体复合物)是Toll样受体4的配体,可使远处的黑色素瘤细胞趋向肺部作为“播种”位点。可能存在未知的S100A8/A9土壤传感器,例如细胞外基质金属蛋白酶诱导剂、神经塑蛋白、活化白细胞细胞黏附分子和黑色素瘤细胞黏附分子。我们将这些受体蛋白称为“新型S100土壤传感器受体(新型SSSRs)”。在此,我们回顾并总结了S100A8/A9-新型SSSRs轴在癌症转移中的关键作用。S100A8/A9与单个SSSRs的结合在癌症转移中很重要,它可通过上调上皮-间质转化、细胞运动性和癌细胞侵袭性,以及在转移器官中形成炎症性免疫抑制环境来实现。这些转移细胞事件是由我们所确定的具有SSSR特征的信号转导引起的,这些信号转导为癌细胞提供了转移动力。为了消除癌细胞的这些转移动力,我们开发了新型生物制剂,可阻止S100A8/A9与SSSRs相互作用,进而在体内有效抑制S100A8/A9介导的肺趋向性转移。